14-day Premium Trial Subscription Try For FreeTry Free
Healthcare providers and public health authorities across the country are struggling to answer complex questions related to the COVID-19 pandemic. Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCA
Carle Health today joined Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in announcing a five ye
Allogene Therapeutics (NASDAQ:ALLO) initiated with Buy rating and $29 (28% upside) price target at SunTrust.Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with Market Perform rating and $8 (1
In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT), with a price target of $40.00. The
In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT

IFR US ECM Calendar

01:05pm, Thursday, 09'th Apr 2020
NEW YORK, April 9 (IFR) -
Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today the pricing of $200.0 million aggregate principal amount of 2.50% convertible senior notes due 2025 (the “n

IFR US ECM Calendar

09:57pm, Wednesday, 08'th Apr 2020
NEW YORK, April 8 (IFR) -
Fly Intel: Pre-market Movers EHTH NVAX PINS UPS FDX RPM SGH GNMK TLGT AMC HCAT GLUU IQ W
Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today that it intends to offer, subject to market conditions and other factors, $175.0 million aggregate principal
Janus Henderson Group PLC increased its position in shares of Health Catalyst (NASDAQ:HCAT) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Secu
Exact Sciences (NASDAQ:EXAS) initiated with an Outperform rating and a $70 (25% upside) price target at Evercore ISI.Health Catalyst (NASDAQ:HCAT) initiated with a Buy rating and a $40 (47% upside) pr
Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst (HCAT) and Okta (OKTA). Health Catalyst (HCAT) Canaccord
Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst ( HCAT – Research Report ) and Okta ( OKTA – Research Report ). Health Catalyst (HCAT) Canaccord G
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced meaningful developments in its in
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE